N,N-diethylbenzo(d)(1,3)diazepin-6-amine
- Molecular formula
- C16H19N3
- CAS Number
- 24014-73-7
- IUPAC Name
- N,N-diethyl-7H-benzo[d][1,3]benzodiazepin-6-amine
- Molecular Weight
- 251.34g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.1260g/cm3
- Appearance
- may slightly vary based on its purity and crystalline form achieved during synthesis or isolation.
Identification
Interesting Facts about N,N-Diethyl-7H-benzo[d][1,3]benzodiazepin-6-amine
N,N-Diethyl-7H-benzo[d][1,3]benzodiazepin-6-amine is a compound that falls within the class of benzodiazepines, which are well-known for their central nervous system (CNS) effects. These compounds are often utilized for their hypnotic, anxiolytic, and muscle relaxant properties. Here are some key insights into this fascinating compound:
- Chemical Structure: This compound features a unique bicyclic core that contains both fused benzene rings and a diazepine structure. This complexity contributes to its pharmacological effects.
- Medicinal Uses: While specific research is ongoing, benzodiazepine derivatives are commonly studied for their potential in treating anxiety disorders, insomnia, and other stress-related conditions.
- Structure-Activity Relationship: The presence of ethyl groups in this compound suggests that modifications to the benzodiazepine structure can significantly influence its potency and side-effect profile. Understanding these relationships is crucial for medicinal chemistry.
- Binding Affinity: Compounds like this one typically bind to GABAA receptors, enhancing the effects of the neurotransmitter GABA. This mechanism highlights the importance of benzodiazepines in neuropharmacology.
- Research Potential: The study of this compound could lead to the development of new therapeutic agents with improved efficacy and safety compared to existing benzodiazepines.
As a scientist or chemistry student, exploring the intricate details of N,N-diethyl-7H-benzo[d][1,3]benzodiazepin-6-amine not only enhances our understanding of its biological implications but also invites further inquiry into how variations in chemical structure can be employed to address modern therapeutic challenges. In the words of renowned pharmacologist William O. Foye, "The future of pharmacology hinges on understanding the subtle nuances of chemical structures and their biological interactions."